U
SVNT

UBS’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

UBS’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-23,000
Closed -$14K – 11352
2013
Q3 		$14K Buy
23,000
+5,700
+33% +$3.65K ﹤0.01% 8522
2013
Q2 		$10K Buy
+17,300
New +$12.1K ﹤0.01% 8687

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

UBS's SVNT Position: Q4 2013 in Review

UBS sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 78,113 shares — an estimated $49K sold.

UBS first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $49K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • UBS reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • UBS sold 78,113 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $49K.
  • UBS first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • UBS's SAVIENT PHARMACEUTICALS INC position peaked at $49K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on UBS's 13F filing for Q4 2013, filed 14 Feb 2014.